Related references
Note: Only part of the references are listed.Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis
Adolfo Diez-Perez et al.
BONE (2019)
Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
M. Hiligsmann et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)
Nicola Napoli et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
Athanasios D. Anastasilakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
Athanasios D. Anastasilakis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Observations following discontinuation of long-term denosumab therapy
M. R. McClung et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
P. Szulc et al.
OSTEOPOROSIS INTERNATIONAL (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
Elena Tsourdi et al.
BONE (2017)
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Robert A. Adler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
P. D. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Cost-effective osteoporosis treatment thresholds in Greece
P. Makras et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop
Shonni J. Silverberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinician's Guide to Prevention and Treatment of Osteoporosis
F. Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
R. Rizzoli et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
Jacques P. Brown et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Incidence of hip fractures in Greece during a 30-year period: 1977-2007
G. P. Lyritis et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: a compendium of country-specific reports
A. Svedbom et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Nelson B. Watts et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Treatment failure in osteoporosis
A. Diez-Perez et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Osteoporosis in young adults: pathophysiology, diagnosis, and management
S. Ferrari et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Interpretation and use of FRAX in clinical practice
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Cost-Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence
Mickael Hiligsmann et al.
VALUE IN HEALTH (2010)
The Utility and Limitations of FRAX: A US Perspective
Stuart L. Silverman et al.
Current Osteoporosis Reports (2010)
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data
A. Cranney et al.
OSTEOPOROSIS INTERNATIONAL (2009)
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions
E. Michael Lewiecki et al.
BONE (2008)
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
Stuart L. Silverman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosis
Socrates Papapoulos et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Reduced risk of back pain following teriparatide treatment: a meta-analysis
MC Nevitt et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Continuing outcomes relevant to evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
S Martino et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women
C Tannenbaum et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Share Paper
